Mega2: Manipulation Environment for Genetic Analyses
Mega2:遗传分析的操作环境
基本信息
- 批准号:8586527
- 负责人:
- 金额:$ 29.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmendmentBackBipolar DisorderCase-Control StudiesChromosome MappingCodeCommunitiesComplexComputational BiologyComputer softwareCoronary ArteriosclerosisCountryDataData SetDatabasesDegenerative polyarthritisDevelopmentDocumentationEnsureEnvironmentEpilepsyFamilyGalaxyGeneticGenetic ProcessesGenetic ResearchGenome ScanGraphHandHealthcareHereditary DiseaseInstitutionInsulin-Dependent Diabetes MellitusMaintenanceMajor Depressive DisorderMalignant neoplasm of lungMalignant neoplasm of prostateMapsNon-Insulin-Dependent Diabetes MellitusObesityOutputPainProcessQuality ControlResearchResearch PersonnelResourcesRheumatoid ArthritisRoleRunningSchizophreniaSoftware EngineeringSpeedTestingValidationabstractingbasebiomedical informaticscomputer programdata formatevaluation/testingfile formatgene discoverygenetic analysisgenetic risk factorgraphical user interfacehuman diseaseimprovedinteroperabilitymeetingsopen sourceportabilityprogramspublic health relevancerepairedtask analysistoolusability
项目摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract Mega2, the Manipulation Environment for Genetic Analysis, is a unique open-source computer program for facilitating the creation of analysis-ready datasets from data gathered as part of a genetic study. Mega2 transparently allows users to process genetic data for family-based or case/control studies accurately and efficiently. In addition to data validation checks, Mega2 provides analysis setup capabilities for a broad choice of commonly-used genetic analysis programs. It has served an important role in the genetics research community worldwide. Under this proposal, we plan to enhance the capabilities of Mega2, while applying best practices in software engineering to meet these critical needs of an open-source project: portability across OS platforms, ability to evolve with the needs of genetics research, extensive documentation, maximizing code reuse, as well as systematic testing, debugging and maintenance. Specifically, we plan to make Mega2 much easier to extend, repair, and maintain by streamlining it and restructuring it as an object-oriented application, implementing an application programming interface and a graphical user interface, and creating a dynamic mechanism for adding new input formats, filters, and output formats. We plan to improve Mega2's large-scale data handling in order to meet the needs of the research community by adding a fast interactive mode, implementing adjustment layers for modifying and filtering original data, and supporting an intermediate pre- validated data format. We plan to extend Mega2's interoperability by supporting more input formats and analysis programs, improving connections to existing databases, and integrating Mega2 within the Galaxy workflow pipeline. We plan to continue to maintain Mega2 as a public resource, constantly revising it to support the very latest versions of the supported analysis programs, carrying out rigorous and extensive quality-control testing, and maintaining and improving the documentation. Accomplishment of these aims will significantly improve Mega2's usability, data input handling capabilities, abilities to set up target analyses, extensibility, maintainability, and interoperability, thus ensuring continuing usefulness and availability of this widely-used software. Mega2 has been used to accelerate gene discovery studies for a large list of complex human diseases. Improving this crucial resource will have a significant impact on speeding up the gene-discovery process, which in turn will ease the healthcare burden due to complex genetic disease in the US and world-wide.
描述(由申请人提供):遗传分析的操纵环境项目摘要/摘要MEGA2是一个独特的开源计算机程序,用于促进作为基因研究的一部分收集的数据创建可分析的数据集。 MEGA2透明地允许用户准确有效地处理基于家庭或病例/控制研究的遗传数据。除了数据验证检查外,MEGA2还提供了分析设置功能,可为常用的遗传分析程序提供广泛的选择。它在全球遗传学研究界发挥了重要作用。根据该提案,我们计划增强MEGA2的功能,同时应用软件工程中的最佳实践来满足开源项目的这些关键需求:跨OS平台的可移植性,随着遗传学研究的需求,广泛的文档,最大化代码重用的需求,最大化代码重复使用,以及系统的测试,调试,调试和维护。具体而言,我们计划通过简化,将其重组为面向对象的应用程序,实现应用程序编程接口和图形用户界面,并创建用于添加新输入格式,过滤器和输出格式的动态机制,从而使MEGA2更容易扩展,维修和维护。我们计划通过添加快速交互模式,实施调整层来修改和过滤原始数据并支持中间的预验证的数据格式,以改善MEGA2的大规模数据处理,以满足研究社区的需求。我们计划通过支持更多的输入格式和分析程序,改善与现有数据库的连接并将MEGA2集成在Galaxy Workflow Pipeline中,以扩展MEGA2的互操作性。我们计划继续将MEGA2保持为公共资源,不断对其进行修改,以支持最新版本的受支持的分析程序,进行严格且广泛的质量控制测试,并维护和改进文档。这些目标的完成将显着提高MEGA2的可用性,数据输入处理能力,设置目标分析的能力,可扩展性,可维护性和互操作性,从而确保此通用软件的持续有用性和可用性。 MEGA2已被用来加速基因发现研究,以供大量复杂的人类疾病。改善这种关键资源将对加速基因发现过程产生重大影响,这反过来又将缓解由于美国和全球范围内复杂的遗传疾病而导致的医疗保健负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel E Weeks其他文献
Daniel E Weeks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel E Weeks', 18)}}的其他基金
Mega2: Manipulation Environment for Genetic Analyses
Mega2:遗传分析的操作环境
- 批准号:
8015837 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega 2: Manipulation Environment for Genetic Analyses
Mega 2:遗传分析的操作环境
- 批准号:
7190578 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega 2: Manipulation Environment for Genetic Analyses
Mega 2:遗传分析的操作环境
- 批准号:
7028164 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega2: Manipulation Environment for Genetic Analyses
Mega2:遗传分析的操作环境
- 批准号:
8206493 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega2: Manipulation Environment for Genetic Analyses
Mega2:遗传分析的操作环境
- 批准号:
8401892 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega 2: Manipulation Environment for Genetic Analyses
Mega 2:遗传分析的操作环境
- 批准号:
7369842 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega 2: Manipulation Environment for Genetic Analyses
Mega 2:遗传分析的操作环境
- 批准号:
7578260 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
Mega 2: Manipulation Environment for Genetic Analyses
Mega 2:遗传分析的操作环境
- 批准号:
8079227 - 财政年份:2006
- 资助金额:
$ 29.76万 - 项目类别:
India-US Research Training Program in Genetics
印度-美国遗传学研究培训项目
- 批准号:
6789422 - 财政年份:2002
- 资助金额:
$ 29.76万 - 项目类别:
India-US Research Training Program in Genetics
印度-美国遗传学研究培训项目
- 批准号:
6663277 - 财政年份:2002
- 资助金额:
$ 29.76万 - 项目类别:
相似国自然基金
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
间质性肺疾病致肺气体交换功能改变的超极化129Xe MRI定量研究
- 批准号:82372150
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
缺血性脑卒中疾病中NLRP6磷酸化修饰的鉴定及其在调控炎性小体活化中的作用和机制研究
- 批准号:82302474
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
小胶质细胞清除后骨髓移植延缓csf1r点突变小鼠疾病进展的机制研究
- 批准号:82301526
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
数据驱动的心血管疾病区域协同医疗服务研究
- 批准号:72301123
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
缓释 PNA5 的 GMP 生产和 IND 启用研究:一种治疗阿尔茨海默氏病相关痴呆和血管性认知障碍患者认知障碍的新疗法
- 批准号:
10819329 - 财政年份:2023
- 资助金额:
$ 29.76万 - 项目类别:
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
PNA5:一种新型 Mas 受体激动剂,用于治疗有血管性痴呆和阿尔茨海默氏病相关痴呆风险的患者的认知障碍:FDA 要求的毒理学研究
- 批准号:
10705874 - 财政年份:2023
- 资助金额:
$ 29.76万 - 项目类别:
Scale-up Manufacturing and IND Enabling Studies of Extended-Release Formulation of Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Alzheimer's Disease-Related Dementias
用于治疗血管认知障碍和阿尔茨海默病相关痴呆的 Mas 受体激动剂缓释制剂的放大生产和 IND 启用研究
- 批准号:
10543390 - 财政年份:2022
- 资助金额:
$ 29.76万 - 项目类别:
Preclinical and early clinical development of a GABA-A a5 PAM
GABA-A a5 PAM 的临床前和早期临床开发
- 批准号:
10686404 - 财政年份:2022
- 资助金额:
$ 29.76万 - 项目类别: